Skip to content
HealthCare Roundtable

Become A Member

  • NEWS & UPDATES
  • PRIORITIES & ENGAGEMENT
  • Events
  • ABOUT US
  • Strategic Relationships
  • CONTACT US
  • NEWS & UPDATES
  • PRIORITIES & ENGAGEMENT
  • Events
  • ABOUT US
  • Strategic Relationships
  • CONTACT US

HealthCare Roundtable e-News – December 19, 2022

generic drugs

HealthCare Roundtable e-News – December 19, 2022

Posted on December 19, 2022December 20, 2022 by HealthCare Roundtable
Posted in Affordable Care Act, e-News, Healthcare, Medicare, NewsletterTagged ACA, biosimilar drugs, cdc, CHIP, CMS, COVID-19, fda, FTC, generic drugs, HHS, maternal care, Medicaid, medicare, medicare advantage, mental health, No Surprise Act, pheLeave a Comment on HealthCare Roundtable e-News – December 19, 2022

HealthCare Roundtable e-News – January 26, 2022

Posted on January 26, 2022January 26, 2022 by HealthCare Roundtable
Posted in Affordable Care Act, e-News, Generic Drugs, Health Insurance, NewsletterTagged ACA, aca coverage, aca enrollment, brand drugs, budget reconciliation, Build Back Better, cbo, generic drugs, HHS, MedPAC, mental health, omnicronLeave a Comment on HealthCare Roundtable e-News – January 26, 2022

HealthCare Roundtable e-News – April 13, 2021

Posted on April 13, 2021April 26, 2021 by HealthCare Roundtable
Posted in e-News, Generic Drugs, NewsletterTagged ACA improvement bill, American Jobs Plan, American Rescue Plan, CMS, drug pricing, FDA inspections, generic drugs, H.R. 3, HHS, nomineeLeave a Comment on HealthCare Roundtable e-News – April 13, 2021

HealthCare Roundtable e-News – Aug. 18, 2017

Posted on August 18, 2017October 11, 2018 by HealthCare Roundtable
Posted in Affordable Care Act, Bipartisan, e-News, Healthcare, MedicalTagged drug, fda, generic drugs, Scott Gottlieb, tax creditLeave a Comment on HealthCare Roundtable e-News – Aug. 18, 2017

HealthCare Roundtable e-News – Aug. 4, 2017

Posted on August 4, 2017October 11, 2018 by HealthCare Roundtable
Posted in Affordable Care Act, Bipartisan, e-News, Health Insurance, Healthcare, MedicalTagged AMA, biologics, biosimilarity, fda, generic drugs, Lamar Alexander, Orrin Hatch, Patty Murray, Ron WydenLeave a Comment on HealthCare Roundtable e-News – Aug. 4, 2017

HealthCare Roundtable e-News – July 28, 2017

Posted on July 28, 2017October 11, 2018 by HealthCare Roundtable
Posted in Affordable Care Act, Bipartisan, e-News, Health Insurance, Healthcare, MedicalTagged 21st Century Cures Act, biologics, biosimilarity, Chuck Schumer, congress, fda, generic drugs, gop, John McCain, Lisa Murkowski, obamacare, Scott Gottlieb, senate, Susan Collins, Tom Marino, TrumpLeave a Comment on HealthCare Roundtable e-News – July 28, 2017

HealthCare Roundtable e-News – July 21, 2017

Posted on July 21, 2017October 11, 2018 by HealthCare Roundtable
Posted in Affordable Care Act, Bipartisan, e-News, Generic Drugs, Health Insurance, HealthcareTagged drug cost, fda, Free for all, generic drugs, Medicaid, medicare for all, Mensing, Pliva, Scott Gottlieb, Susan Collins, Ted CruzLeave a Comment on HealthCare Roundtable e-News – July 21, 2017

HealthCare Roundtable e-News – July 14, 2017

Posted on July 14, 2017October 11, 2018 by HealthCare Roundtable
Posted in Affordable Care Act, Bipartisan, e-News, Generic Drugs, Health Insurance, Healthcare, MedicalTagged calPERS, congress, fda, generic drugs, Greg Walden, healthcare reform, John McCain, Medicaid, Mitch McConnell, republican health plan, Ron Johnson, senate, tax creditsLeave a Comment on HealthCare Roundtable e-News – July 14, 2017
Post Office Box 26368, Alexandria, VA 22313  |  978.835.5424  |  info@healthcareroundtable.org